Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.
A June 2018 review said that pandemic plans everywhere were inadequate, since natural viruses can emerge with over 50% case fatality rates, but health professionals and policy makers planned as if pandemics would never exceed the 2.5% case fatality rate of the Spanish flu pandemic in 1918. In the years leading up to the COVID-19 pandemic, several governments ran demonstration exercises (including Crimson Contagion) which proved that most countries would be underprepared. Neither governments nor big businesses took action. Several reports underlined the inability of national governments to learn from the previous disease outbreaks, epidemics and pandemics. Richard Horton, editor-in-chief of The Lancet, described the "global response to SARS-CoV-2 [as] the greatest science policy failure in a generation".
Early outbreaks in Hubei, Italy and Spain showed that several wealthy countries' health care systems were overwhelmed. In developing countries with weaker medical infrastructure, equipment for intensive care beds and other medical needs, shortages were expected to occur earlier.
International
The World Health Organization (WHO) and the World Bank warned about the risk of pandemics throughout the 2000s and the 2010s, especially after the 2002–2004 SARS outbreak. The Global Preparedness Monitoring Board released its first report in late 2019. Private initiatives also raised awareness about pandemic threats and needs for better preparedness. In 2018, the WHO coined the term, Disease X, which "represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease" in order to focus research and development on likely candidates for the next, at-the-time unknown, pandemic.
International divisions and lack of suitable collaboration limited preparedness. WHO's pandemic influenza preparedness project had a million two-year budget, out of WHO's 2020–2021 budget of billion.
A number of organizations have been involved for years preparing the world for epidemics and pandemics. Among those is the Coalition for Epidemic Preparedness Innovations, co-founded by the Bill & Melinda Gates Foundation, Wellcome Trust, and the European Commission. Since 2017 the Coalition has tried to produce a platform approach for dealing with emerging epidemic disease such as COVID-19, which would enable rapid vaccine development and immunity research in response to outbreaks. A significant real-time pandemic exercise shortly before the COVID-19 outbreak was "The Event 201 Scenario" sponsored by the WHO, Johns Hopkins Center for Health Security and the Bill & Melinda Gates Foundation. Held in October 2019, the exercise dealt with the importance of securing the co-operation of government and health authorities worldwide during any future pandemic, with a special emphasis on means to combat the spread of misinformation and disinformation through the media.
Countries
France
Following warnings and increased preparedness in the 2000s, the 2009 swine flu pandemic led to rapid anti-pandemic reactions among the Western countries. The H1N1/09 virus strain with mild symptoms and low lethality eventually led to a backlash over public sector over-reactiveness, spending and the high cost of the 2009 flu vaccine. In the following years, national strategic stockpiles of medical equipment were not systematically renewed. In France, a million purchase of masks, vaccines and others for H1N1 under the responsibility of the Minister of Health Roselyne Bachelot was widely criticized.
The French health authorities decided in 2011 not to replenish their stocks in order to reduce acquisitions and storage costs and rely more on supplies from China and just-in-time logistics and distribute the responsibility to private companies on an optional basis. The French strategic stockpile dropped in this period from one billion surgical masks and 600 million FFP2 masks in 2010 to 150 million and zero, respectively in early 2020.